Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human papillomavirus oncoproteins.

K H Vousden1

  • 1Ludwig Institute for Cancer Research, St. Mary's Hospital Medical School, London, UK.

Seminars in Cancer Biology
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

p53- and p73-independent activation of TIGAR expression in vivo.

Cell death & disease·2015
Same author

Functional interplay between MDM2, p63/p73 and mutant p53.

Oncogene·2014
Same author

Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo.

Cell death and differentiation·2014
Same author

Suppression of acetate mutants in Coprinus : I. Identification of two isoaccepting tRNA suppressors of a missense mutation.

Current genetics·2013
Same author

Suppression of acetate mutants in Coprinus : II. Correlation of recessiveness and dosage effects with suppressed enzyme level.

Current genetics·2013
Same author

Functions of TAp63 and p53 in restraining the development of metastatic cancer.

Oncogene·2013
Same journal

Role of oral microbiome in cancer immunotherapy.

Seminars in cancer biology·2026
Same journal

Unveiling tumor heterogeneity by single cell RNA-sequencing: From basic considerations to clinical applications.

Seminars in cancer biology·2026
Same journal

Hidden architecture of resistance: The extracellular matrix in melanoma's immune landscape.

Seminars in cancer biology·2026
Same journal

Microfluidic technologies for extracellular vesicle isolation and analysis: Implications for translational applications in cancer therapy.

Seminars in cancer biology·2026
Same journal

Exploring glioblastoma microenvironment using organoids: opportunities, limitations, and emerging concepts.

Seminars in cancer biology·2026
Same journal

Special issue: Lipid metabolic alterations in cancer: Pathogenic mechanisms, therapies and common pathophysiology with cardiovascular disease.

Seminars in cancer biology·2026
See all related articles

Human papillomaviruses (HPVs) are linked to many cancers. Their E6 and E7 proteins are crucial for malignant development by interacting with tumor suppressor genes.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Human papillomaviruses (HPVs) are implicated in the development of numerous human cancers.
  • Viral oncoproteins E6 and E7 are key factors in HPV-driven malignant progression.

Purpose of the Study:

  • To investigate the role of HPV E6 and E7 proteins in cancer etiology.
  • To understand the functional mechanisms of HPV oncoproteins in cellular transformation.

Main Methods:

  • Analysis of viral gene expression in carcinomas.
  • Functional studies of HPV E6 and E7 transforming and immortalizing activities.
  • Investigation of interactions between viral proteins and cellular tumor suppressor genes.

Main Results:

Related Experiment Videos

  • HPV E6 and E7 proteins possess transforming and immortalizing capabilities.
  • These viral proteins resemble transforming proteins of other DNA tumor viruses.
  • HPV E6 and E7 proteins bind to cellular tumor suppressor gene products, p53 and RB.

Conclusions:

  • HPV E6 and E7 proteins are critical oncogenes in HPV-associated malignancies.
  • The interaction of viral oncoproteins with tumor suppressors (p53, RB) is a key mechanism in cancer development.
  • This highlights a significant link between viral oncogenes and cellular anti-oncogenes.